Chinese equities

China misses out on AI boom as stocks trail by most since 2001

Rather than rapid speculative surges, Beijing wants equities to rise gradually over time, generating stable dividend income and encouraging long-term investment behaviour.

Can China’s ‘slow bull’ market succeed?

From China’s DeepSeek and autonomous driving to South Korea’s memory chips, Asia has proved itself a leader in the AI race.

Asia’s domestic strength amid diversification

Reforms to India’s complicated consumption tax system are a long time coming.

Volatility strikes again: Why investors shouldn’t panic

Major tech stocks like Palantir and Nvidia slid this week.

Tech wobbles, Fed watch, and Asia’s balancing act

A US$10,000 investment in the S&P 500 Index a decade ago would now have more than trebled in value, while the same amount in China’s CSI 300 benchmark would’ve added just around US$3,000.

China’s US$11 trillion stock market is a headache for both Xi and Trump

In H1, IPOs and cross-listings on HKEX totalled 210 deals, raising US$49.2 billion – more than nine times the US$5.3 billion raised a year ago, based on S&P Global Market Intelligence data.

South-east Asian firms test Hong Kong waters amid IPO surge

On a historical basis, Chinese equities are trading at valuations that are "well below" long-term averages, notes Stuart Rumble, Fidelity's head of investment directing for the Asia-Pacific.

Fidelity sees deep value in ‘boring’ China sectors like beer and machinery

China Medical System expects the secondary listing will help it deepen its presence in South-east Asia and “tap into a new and sophisticated investor base in Singapore”.

Hong Kong-listed China Medical System seeks secondary listing on SGX

BlackRock's Ben Powell believes that AI remains a “mega force” that will continue to boost US equities in the upcoming six- to 12-month period.

AI boom for US stocks still a safe bet, less so for China: BlackRock